Humana Past Earnings Performance
Past criteria checks 2/6
Humana has been growing earnings at an average annual rate of 0.6%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 11.8% per year. Humana's return on equity is 12.3%, and it has net margins of 1.8%.
Key information
0.6%
Earnings growth rate
2.4%
EPS growth rate
Healthcare Industry Growth | 12.6% |
Revenue growth rate | 11.8% |
Return on equity | 12.3% |
Net Margin | 1.8% |
Next Earnings Update | 01 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Humana makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 109,243 | 1,991 | 12,661 | 0 |
31 Dec 23 | 106,374 | 2,489 | 12,627 | 0 |
30 Sep 23 | 102,351 | 3,015 | 12,567 | 0 |
30 Jun 23 | 98,727 | 3,378 | 12,342 | 0 |
31 Mar 23 | 95,642 | 3,115 | 12,291 | 0 |
31 Dec 22 | 92,870 | 2,806 | 12,198 | 0 |
30 Sep 22 | 91,485 | 2,807 | 12,230 | 0 |
30 Jun 22 | 90,512 | 3,143 | 11,854 | 0 |
31 Mar 22 | 87,495 | 3,035 | 11,000 | 0 |
31 Dec 21 | 83,064 | 2,933 | 10,121 | 0 |
30 Sep 21 | 82,201 | 2,673 | 9,794 | 0 |
30 Jun 21 | 80,450 | 2,482 | 9,704 | 0 |
31 Mar 21 | 78,888 | 3,722 | 9,942 | 0 |
31 Dec 20 | 77,155 | 3,367 | 10,052 | 0 |
30 Sep 20 | 74,388 | 4,153 | 9,066 | 0 |
30 Jun 20 | 70,554 | 3,502 | 8,442 | 0 |
31 Mar 20 | 67,716 | 2,614 | 7,791 | 0 |
31 Dec 19 | 64,888 | 2,707 | 7,381 | 0 |
30 Sep 19 | 62,761 | 2,550 | 7,367 | 0 |
30 Jun 19 | 60,726 | 2,505 | 7,378 | 0 |
31 Mar 19 | 58,740 | 1,758 | 7,436 | 0 |
31 Dec 18 | 56,912 | 1,683 | 7,525 | 0 |
30 Sep 18 | 55,933 | 1,512 | 7,135 | 0 |
30 Jun 18 | 55,009 | 1,367 | 6,923 | 0 |
31 Mar 18 | 54,284 | 1,824 | 6,615 | 0 |
31 Dec 17 | 53,767 | 2,448 | 6,419 | 0 |
30 Sep 17 | 53,456 | 1,863 | 6,695 | 0 |
30 Jun 17 | 53,868 | 1,814 | 6,746 | 0 |
31 Mar 17 | 54,341 | 1,475 | 6,992 | 0 |
31 Dec 16 | 54,379 | 614 | 7,173 | 0 |
30 Sep 16 | 54,862 | 1,116 | 7,028 | 0 |
30 Jun 16 | 54,531 | 980 | 6,966 | 0 |
31 Mar 16 | 54,256 | 1,100 | 7,084 | 0 |
31 Dec 15 | 54,289 | 1,276 | 7,295 | 0 |
30 Sep 15 | 53,256 | 1,320 | 7,560 | 0 |
30 Jun 15 | 52,131 | 1,296 | 7,781 | 0 |
31 Mar 15 | 50,621 | 1,209 | 7,799 | 0 |
31 Dec 14 | 48,500 | 1,147 | 7,639 | 0 |
30 Sep 14 | 46,359 | 972 | 7,426 | 0 |
30 Jun 14 | 44,440 | 1,050 | 7,068 | 0 |
31 Mar 14 | 42,539 | 1,126 | 6,694 | 0 |
31 Dec 13 | 41,313 | 1,231 | 6,355 | 0 |
30 Sep 13 | 40,683 | 1,453 | 6,102 | 0 |
30 Jun 13 | 40,015 | 1,511 | 5,970 | 0 |
Quality Earnings: 0J6Z has high quality earnings.
Growing Profit Margin: 0J6Z's current net profit margins (1.8%) are lower than last year (3.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0J6Z's earnings have grown by 0.6% per year over the past 5 years.
Accelerating Growth: 0J6Z's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 0J6Z had negative earnings growth (-36.1%) over the past year, making it difficult to compare to the Healthcare industry average (2%).
Return on Equity
High ROE: 0J6Z's Return on Equity (12.3%) is considered low.